These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38007387)

  • 21. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
    Zhao C; Chen H; Wang H; Liu W; Zhuo C; Chu Y; Zeng J; Jin Y; Hu Z; Zhang R; Cao B; Liao K; Hu B; Xu X; Luo Y; Zou M; Su D; Wang Y; Tian B; Zhou H; Liu Y; Guo P; Zhou C; Chen X; Wang Z; Zhang F
    Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(22):1739-46. PubMed ID: 26704158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial resistance of selected invasive bacteria in a tertiary care center: results of a prospective surveillance study.
    Djuric O; Jovanovic S; Stosovic B; Tosic T; Jovanovic M; Markovic-Denic L
    J Infect Dev Ctries; 2016 Dec; 10(12):1325-1331. PubMed ID: 28036312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
    Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
    Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
    Jarlier V; Diaz Högberg L; Heuer OE; Campos J; Eckmanns T; Giske CG; Grundmann H; Johnson AP; Kahlmeter G; Monen J; Pantosti A; Rossolini GM; van de Sande-Bruinsma N; Vatopoulos A; Żabicka D; Žemličková H; Monnet DL; Simonsen GS;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of antibiotic resistance patterns in Central Taiwan during the COVID-19 pandemic: A retrospective study.
    Tseng YW; Huang CW; Chen CC; Er TK
    J Infect Public Health; 2024 Feb; 17(2):229-235. PubMed ID: 38118294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
    Biedenbach DJ; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):59-69. PubMed ID: 15380279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
    Zhang F; Li Y; Lv Y; Zheng B; Xue F
    J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015.
    Kim D; Ahn JY; Lee CH; Jang SJ; Lee H; Yong D; Jeong SH; Lee K
    Ann Lab Med; 2017 May; 37(3):231-239. PubMed ID: 28224769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol.
    Anaya-Baz B; Maldonado N; Palacios-Baena ZR; Palomo V; Pezzani MD; Chiesi S; Razzaboni E; Compri M; Tacconelli E; Rodriguez-Baño J
    BMJ Open; 2020 May; 10(5):e030608. PubMed ID: 32371505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
    Seifert H; Blondeau J; Dowzicky MJ
    Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological profiles and antimicrobial resistance patterns of pediatric bloodstream pathogens in China, 2016-2018.
    Qiu Y; Yang J; Chen Y; Yang J; Zhu Q; Zhu C; Li S; Liu J; Wan C; Zhu Y; Chen M; Xu Y; Tong J; Li R; Shan Q; Lin D; Wu S; Zhuo Z; Wang C; Zhao S; Qi Z; Sun X; Maihebuba B; Jia C; Gao H; Cheng Y; Zeng M;
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):739-749. PubMed ID: 33078219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The real-world impact of the BioFire FilmArray blood culture identification 2 panel on antimicrobial stewardship among patients with bloodstream infections in intensive care units with a high burden of drug-resistant pathogens.
    Chen HY; Tseng HY; Chen CL; Lin YC; Liang SJ; Tu CY; Chen WC; Hsueh PR
    J Microbiol Immunol Infect; 2024 Aug; 57(4):580-593. PubMed ID: 38942661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET).
    Hu F; Yuan L; Yang Y; Xu Y; Huang Y; Hu Y; Ai X; Zhuo C; Su D; Shan B; Du Y; Yu Y; Lin J; Sun Z; Chen Z; Xu Y; Zhang X; Wang C; He L; Ni Y; Zhang Y; Lin D; Zhu D; Zhang Y
    Front Cell Infect Microbiol; 2022; 12():1075185. PubMed ID: 36590586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
    Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
    Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug-resistant organisms may be associated with bed allocation and utilization efficiency in healthcare institutions, based on national monitoring data from China (2014-2020).
    Wang XT; Meng H; Pan DF; Zheng XY; Lu WW; Chen C; Su M; Su XY; Liu Z; Ma XJ; Liang PF
    Sci Rep; 2023 Dec; 13(1):22055. PubMed ID: 38087043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.